Basic info
Industry
biotechnology
Sectors
Chronic Hepatitis B
Regulatory Grade Data
Research Registry
Asthma
Inflammatory Bowel Disease
Primary Biliary Cholangitis
Value Evidence
Patient data
Health Care
Hepatocellular Carcinoma
Health Evidence Solutions
Nonalcoholic Steatohepatitis
Data linking
Immune-Mediated Inflammatory Skin Conditions
Real-world data
Medical
Real-world evidence
Date founded
2015
Funding rounds raised
Total raised
$638K
from 2 investors over 2 rounds
T
TARGET PharmaSolutions raised undisclosed on December 1, 2016
Investors: VentureSouth
T
TARGET PharmaSolutions raised $638K on January 20, 2016
Investors: VentureSouth